Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-9-27
|
pubmed:databankReference | |
pubmed:abstractText |
Opioid compounds have potent analgesic and euphoric properties. They act with specific cell-membrane receptors which have been pharmacologically defined into three major classes, mu, kappa and delta. These receptors are highly regulated with respect to their gene expression, resulting in a temporally and spatially specific pattern of distribution for each receptor. To characterize the promoter sequence of the mu opioid receptor (MOR) gene, a mouse genomic DNA library was screened under high stringency with a rat MOR (MOR-1) cDNA probe and genomic sequences for the mouse MOR gene were isolated. From one genomic clone, a 2.3-kb EcoRI fragment, which hybridized to the 5'-end of the rat MOR-1 cDNA probe, was subcloned and sequenced. This fragment contains 1.3 kb of sequence upstream of the initiation codon, extends downstream through exon 1 and includes a portion of intron 1. Primer extension analysis using mouse brain poly (A)+ RNA identified a transcription initiation site 793 bp upstream from the translation start site. Chimeric constructs of mouse MOR deletion fragments fused to a luciferase reporter gene were transfected into a human neuroblastoma cell line, SK-N-SH, which constitutively expresses endogenous MOR. These transient expression studies indicated that the 0.2-kb region upstream from the transcription initiation site possesses a functional promoter, which directs the expression of the reporter gene in vitro and may possess promoter activity for the mouse MOR gene in vivo.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
679
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
82-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:7648268-Animals,
pubmed-meshheading:7648268-Base Sequence,
pubmed-meshheading:7648268-Cloning, Molecular,
pubmed-meshheading:7648268-Gene Expression Regulation,
pubmed-meshheading:7648268-Mice,
pubmed-meshheading:7648268-Molecular Sequence Data,
pubmed-meshheading:7648268-Peptide Chain Initiation, Translational,
pubmed-meshheading:7648268-Polymerase Chain Reaction,
pubmed-meshheading:7648268-Promoter Regions, Genetic,
pubmed-meshheading:7648268-Receptors, Opioid, mu,
pubmed-meshheading:7648268-Transfection
|
pubmed:year |
1995
|
pubmed:articleTitle |
Cloning and characterization of the promoter region of the mouse mu opioid receptor gene.
|
pubmed:affiliation |
Department of Pharmacology and Toxicology, Indianapolis, IN 46202-5121, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|